SCHEMBL6790340

SCHEMBL6790340

Cc1ccc(Oc2ccc(-c3cccs3)cc2)cc1C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.54
NPSR1 Q6W5P4 1/20 0.54
KMT2A Q03164 4/20 0.48
MAPT P10636 3/20 0.48
MEN1 O00255 2/20 0.48
HPGD P15428 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
LTA4H P09960 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
LMNA P02545 1/20 0.42
GFER P55789 1/20 0.42
KCNH2 Q12809 2/20 0.41
ICAM1 P05362 1/20 0.40
SELE P16581 1/20 0.40
VCAM1 P19320 1/20 0.40
KDM4E B2RXH2 2/20 0.40
HRH3 Q9Y5N1 1/20 0.39
LPL P06858 1/20 0.39
LIPG Q9Y5X9 1/20 0.39
PRMT6 Q96LA8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9796767 0.84 LTA4H (0.55) ALDH1A1KMT2AMAPTMEN1HPGD
SCHEMBL9335104 0.81 KCNH2 (0.55) ALDH1A1NPSR1SMN1; SMN2LTA4HKCNH2
SCHEMBL5641149 0.79 LTA4H (0.50) ALDH1A1MAPTLTA4HLMNAKCNH2
SCHEMBL10259158 0.78 SMN1; SMN2 (0.62) ALDH1A1KMT2AMAPTMEN1HPGD
SCHEMBL47864 0.76 KMT2A (0.60) ALDH1A1KMT2AMAPTMEN1HPGD
SCHEMBL10993100 0.76 KMT2A (0.60) ALDH1A1KMT2AMAPTMEN1HPGD
SCHEMBL21858144 0.76 ALDH1A1 (0.47) ALDH1A1NPSR1KMT2AMAPTMEN1
SCHEMBL8005625 0.76 PPARG (0.53) MAPTSMN1; SMN2LTA4HKCNH2KDM4E
SCHEMBL14542301 0.76 ESR1 (0.52) KMT2AMAPTMEN1SMN1; SMN2LTA4H
SCHEMBL7299255 0.75 LTA4H (0.46) ALDH1A1KMT2AMAPTMEN1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040097487-A1 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds G.D. SEARLE & CO. 2004-05-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040097487-A1 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds MMP1, MMP2, MMP10 ALDH1A1 839/4885NPSR1 2297/4885KMT2A 1233/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.